1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B925CF1A5E1E099F002587550017BA3E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew!SearchView&Query=(Field ph=T and FIELD+publishdate+>=+1/11/2007)+AND+(the)+and+(field+ItemCatalog=DB)&SearchWV=1&SearchFuzzy=1&SearchOrder=1&Start=1&Count=10
18
19SearchView&Query=(Field%20ph=T%20and%20FIELD%20publishdate%20%3E=%201/11/2007)%20AND%20(the)%20and%20(field%20ItemCatalog=DB)&SearchWV=1&SearchFuzzy=1&SearchOrder=1&Start=1&Count=10
2035.172.203.87
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Search Results

Results 1 - 10 of 532 Total Hits, .

    |    

DB Image

Cariprazine: The Market Landscape for a Second-Generation Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

STUDY OVERVIEW This short case study examines cariprazine, a second-generation atypical antipsychotic therapy developed by Forest Laboratories and Gedeon Richter... (ID 5302)
Companies Profiled: Forest Laboratories, Gedeon Richter Ltd.

$200.00

DB Image

Using Disease Management Systems to Thwart Generic Competitors: A Case StudyDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Companies seeking to develop strategies and tactics that enhance the post-patent success of products can learn from products that maintained market share in the face of generic competition... (ID 4246)
Companies Profiled: Novartis

$574.95

DB Image

Library Services Staffing MetricsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Library Services Staffing Metrics" STUDY OVERVIEW Company libraries provide valuabl... (ID 5329)
Companies Profiled: Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, Eisai, Eli Lilly, more ...

DB Image

Assessing Gamification Technologies and Approaches for the Pharma SectorDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

STUDY OVERVIEW The use of game elements to capture consumer's attention makes sense for business functions such as marketing or human resources... (ID 5294)
Companies Profiled: Eli Lilly, Genentech, Boehringer Ingelheim

$500.00

DB Image

Zyprexa: Portrait of a Successful Lifecycle for an Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

STUDY OVERVIEW This 4-page case study examines Zyprexa, the third atypical antipsychotic therapy when it was approved in 1996 by the FDA... (ID 5303)
Companies Profiled: Eli Lilly

$200.00

DB Image

Vectibix Case Study: How Amgen Collaborated with the Colon Cancer Alliance to Ensure Market EducationDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

This case study reviews how Amgen interacted with a leading patient advocacy group to support Vectibix, a colorectal cancer treatment... (ID 5067)
Companies Profiled: Amgen

DB Image

Slentrol Case Study: Using Integrated PR Tactics to Support a Product LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-Members: To download a complimentary excerpt of this study, please click here... (ID 5014)
Companies Profiled: Pfizer Animal Health

DB Image

RINVOQ Case Analysis: Summoning the Right Sales Resources to Support a New Blockbuster’s LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “RINVOQ Case Analysis: Summoning the Right Sales Resources to Support a New Blockbuste... (ID 5675)
Companies Profiled: AbbVie

DB Image

ULTOMIRIS Case Analysis: Summoning the Right Sales Resources to Support a New Blockbuster’s LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "ULTOMIRIS Case Analysis: Summoning the Right Sales Resources to Support a New Blockbu... (ID 5682)
Companies Profiled: Alexion Pharmaceuticals

DB Image

Skyrizi Case Analysis: Summoning the Right Sales Resources to Support a New Blockbuster’s LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Skyrizi Case Analysis: Summoning the Right Sales Resources to Support a New Blockbust... (ID 5669)
Companies Profiled: AbbVie